2007
DOI: 10.1253/circj.71.261
|View full text |Cite
|
Sign up to set email alerts
|

Genetic Aspects of the Vascular Type of Ehlers-Danlos Syndrome (vEDS, EDSIV) in Japan

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

1
25
1

Year Published

2008
2008
2014
2014

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 35 publications
(27 citation statements)
references
References 20 publications
1
25
1
Order By: Relevance
“…This produces abnormal secretion, synthesis, and structure of type III collagen, which is decreased or absent. 8,9 Clinically, patients have fragile, translucent skin with the underlying vessels clearly visible. Patients are usually underweight, of short stature, and have a characteristic facial appearance with a thin, pinched nose and prominent eyes.…”
Section: Discussionmentioning
confidence: 99%
“…This produces abnormal secretion, synthesis, and structure of type III collagen, which is decreased or absent. 8,9 Clinically, patients have fragile, translucent skin with the underlying vessels clearly visible. Patients are usually underweight, of short stature, and have a characteristic facial appearance with a thin, pinched nose and prominent eyes.…”
Section: Discussionmentioning
confidence: 99%
“…[1][2][3][4] vEDS is characterized by four clinical criteria: easy bruising, thin skin with visible veins, characteristic facial features, and the rupturing of arteries and organs. [1][2][3][4] In addition, classic EDS patients exhibit hypermobility of the large joints and hyperextensibility of the skin. 1,2 Typically, Ehlers-Danlos syndrome (EDS) is divided into six types, and vEDS patients follow a particularly poor clinical course caused by complications from tissue weakness.…”
Section: Introductionmentioning
confidence: 99%
“…The quantitative or qualitative deficit of structurally normal collagen III in vEDS and corresponding changes in the wall structure are responsible for major complications observed in afflicted individuals: arterial, bowel, and uterine ruptures. As a result of these dramatic complications, life expectancy in vEDS is shortened to a mean of Ͻ50 years (Pepin et al, 2000;Watanabe et al, 2007). Until recently, there was no evidence-based treatment or preventive strategy available (Watanabe and Shimada, 2008).…”
Section: Introductionmentioning
confidence: 99%